Amgen settles with FTC over US$28 billion deal
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
CiplaMed 2.0 leverages advanced analytics and automation
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Qualifyze specializes in Good Practice audits (GxP) audits and covers a wide range of areas, including excipients, starting materials, packaging, sustainability
Subscribe To Our Newsletter & Stay Updated